These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38871657)

  • 1. Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial.
    D'Aragon F; Selzner M; Breau R; Masse MH; Lamontagne F; Masse M; Chassé M; Carrier FM; Cardinal H; Chaudhury P; Weiss M; Lauzier F; Turgeon AF; Frenette AJ; Bolduc B; Ducharme A; Lamarche C; Couture E; Holdsworth S; Bertholz L; Talbot H; Slessarev M; Luke P; Boyd JG; Shamseddin MK; Burns KEA; Zaltzman J; English S; Knoll G; Dhanani S; Healey A; Hanna S; Rochwerg B; Oczkowski SJW; Treleaven D; Meade M;
    BMJ Open; 2024 Jun; 14(6):e086777. PubMed ID: 38871657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT).
    Krogstrup NV; Oltean M; Bibby BM; Nieuwenhuijs-Moeke GJ; Dor FJ; Birn H; Jespersen B
    BMJ Open; 2015 Aug; 5(8):e007941. PubMed ID: 26297360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials.
    Schröppel B; Akalin E; Baweja M; Bloom RD; Florman S; Goldstein M; Haydel B; Hricik DE; Kulkarni S; Levine M; Mehrotra A; Patel A; Poggio ED; Ratner L; Shapiro R; Heeger PS
    Am J Transplant; 2020 Feb; 20(2):564-572. PubMed ID: 31452319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients.
    de Boer SE; Sanders JSF; Bemelman FJ; Betjes MGH; Burgerhof JGM; Hilbrands L; Kuypers D; van Munster BC; Nurmohamed SA; de Vries APJ; van Zuilen AD; Hesselink DA; Berger SP
    BMC Nephrol; 2021 Jun; 22(1):208. PubMed ID: 34078323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Preconditioning of Donors After Brain Death With Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation.
    Abbasi Dezfouli S; Nikdad M; Ghamarnejad O; Khajeh E; Arefidoust A; Mohammadi S; Majlesara A; Sabagh M; Gharabaghi N; Kentar M; Younsi A; Eckert C; Poth T; Golriz M; Mehrabi A; Nickkholgh A
    Front Immunol; 2020; 11():1222. PubMed ID: 32625210
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME).
    Brulé N; Canet E; Péré M; Feuillet F; Hourmant M; Asehnoune K; Rozec B; Duveau A; Dube L; Pierrot M; Humbert S; Tirot P; Boyer JM; Martin-Lefevre L; Labadie F; Robert R; Benard T; Kerforne T; Thierry A; Lesieur O; Vincent JF; Lesouhaitier M; Larmet R; Vigneau C; Goepp A; Bouju P; Quentin C; Egreteau PY; Huet O; Renault A; Le Meur Y; Venhard JC; Buchler M; Michel O; Voellmy MH; Herve F; Schnell D; Courte A; Glotz D; Amrouche L; Hazzan M; Kamar N; Moal V; Bourenne J; Le Quintrec-Donnette M; Morelon E; Boulain T; Grimbert P; Heng AE; Merville P; Garin A; Hiesse C; Fermier B; Mousson C; Guyot-Colosio C; Bouvier N; Rerolle JP; Durrbach A; Drouin S; Caillard S; Frimat L; Girerd S; Albano L; Rostaing L; Bertrand D; Hertig A; Westeel PF; Montini F; Delpierre E; Dorez D; Alamartine E; Ouisse C; Sebille V; Reignier J
    BMJ Open; 2022 Mar; 12(3):e052845. PubMed ID: 35351701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors.
    D'Aragon F; Dhanani S; Lamontagne F; Cook DJ; Burns K; Akhtar A; Chassé M; Frenette AJ; Keenan S; Lize JF; Kutsogiannis DJ; Kramer A; Hand LE; Arseneau E; Masse MH; Ribic C; Ball I; Baker A; Boyd G; Rochwerg B; Healey A; Hanna S; Guyatt GH; Meade MO;
    BMJ Open; 2017 Sep; 7(9):e018858. PubMed ID: 28963316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium canrenoate in brain-dead organ donors: a randomised controlled clinical trial protocol (CANREO-PMO).
    Belarif L; Girerd S; Jaisser F; Lepage X; Merckle L; Duarte K; Girerd N; Guerci P
    BMJ Open; 2023 Oct; 13(10):e073831. PubMed ID: 37821131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hamilton-DONATE: a city-wide pilot observational study of the ICU management of deceased organ donors.
    D'Aragon F; Cook D; Dhanani S; Ribic C; Burns KEA; Akhtar A; Hand L; Arseneau E; Cupido C; Whittigham H; Healey A; Frenette AJ; Lamontagne F; Meade MO;
    Can J Anaesth; 2018 Oct; 65(10):1110-1119. PubMed ID: 29987806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK
    Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.
    Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJ; Møldrup U; Krag SP; Bibby BM; Birn H; Jespersen B
    Am J Transplant; 2017 Apr; 17(4):1042-1049. PubMed ID: 27696662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.
    Kainz A; Wilflingseder J; Mitterbauer C; Haller M; Burghuber C; Perco P; Langer RM; Heinze G; Oberbauer R
    Ann Intern Med; 2010 Aug; 153(4):222-30. PubMed ID: 20713790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 37-year kidney transplantation experience at Siriraj Hospital.
    Premasathian N; Vongwiwatana A; Taweemonkongsap T; Amornvesukit T; Limsrichamrern S; Jitpraphai S; Kositamongkol P; Mahawithitwong P; Sritippayawan S; Chanchairujira T; Nualyong C; Vareesangthip K; Vasuvattakul S; Sirivatanauksorn Y
    Clin Transpl; 2010; ():141-8. PubMed ID: 21696037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.
    Dugast E; Soulillou JP; Foucher Y; Papuchon E; Guerif P; Paul C; Riochet D; Chesneau M; Cesbron A; Renaudin K; Dantal J; Giral M; Brouard S
    Am J Transplant; 2016 Nov; 16(11):3255-3261. PubMed ID: 27367750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.
    Tingle SJ; Figueiredo RS; Moir JA; Goodfellow M; Talbot D; Wilson CH
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011671. PubMed ID: 30875082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.